The $369 million Grasshopper deal is dead, the stock lost more than a fifth of its value, and one analyst note reframed the problem as a sector issue.
Enova International (NYSE: ENVA) withdrew the federal applications required to complete its roughly $369 million acquisition of Grasshopper Bancorp on September 14. Shares fell roughly 22% by the open on September 15. The stock traded at $171.89 late Wednesday, down 0.99% from Tuesday's $173.61 close, with a 50-day average of $239.43 showing how much of the decline is recent.
Two analysts responded this week by cutting targets while maintaining positive ratings. TD Cowen reduced its price target to $220 from $257 and maintained a Buy rating. Citizens reduced its target to $215 from $270 and maintained a Market Outperform rating.
On Wednesday, three shareholder firms announced investigations into potential securities law violations: Wolf Popper, Levi and Korsinsky, and Glancy Prongay Wolke and Rotter. None has filed a complaint, and an announced investigation establishes nothing about the merits.
The framing in the Citizens note is the part that travels
Citizens tied its reduction not to Enova's execution but to the approval process itself, noting that the regulatory process "did not have clear standards for non-traditional, non-bank lenders."
That is a claim about the regime, not about the company. If it is correct, the repricing should not stop at Enova. Any non-bank consumer or small-business lender pursuing a bank charter faces the same absence of defined standards, and any such company's disclosed charter ambition now carries a visible approval-risk discount that was not being applied a week ago.
The limitation is that this remains one analyst's interpretation. No peer with a comparable disclosed charter ambition has been identified and tested against the framing, which leaves the sector-wide reading an argument rather than a demonstrated pattern.
What the company's own behavior says
There is a direct countersignal to a fundamentals-are-broken reading. Enova reaffirmed guidance and signaled accelerated buyback activity alongside the withdrawal. A company that believed its earnings power had been impaired does not normally lean into repurchases at the same moment.
That supports the alternative interpretation: the charter was optionality, not the business. A bank charter would have lowered Enova's funding costs by giving it access to deposits instead of wholesale funding. Losing that option removes an upside case for the cost of funds; it does not damage the existing lending operation.
The rate environment cuts both ways here. The Federal Reserve raised rates to 3.75% to 4.00% on Wednesday and its officials project further increases, which raises the value of the deposit funding Enova will not now be getting, and simultaneously raises the yield the company can charge on new originations.
The unresolved pieces
A second filing dated September 15 exists on the company's investor relations page, and its contents have not been reviewed. Reporting that roughly 20 state attorneys general asked regulators to deny the charter has not been matched to any named, on-the-record statement tied to this withdrawal. Whether any of the announced investigations becomes an actual complaint is unknown.